Drupal.behaviors.print = function(context) {window.print();window.close();}>

Warnex Licenses Rights to Cancer Dx Technology from Epigenomics

May 03, 2010

Warnex Licenses Rights to Cancer Dx Technology from Epigenomics

Warnex will produce a laboratory-developed colorectal cancer test and offer it as a testing service in Canada.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories